RCI scientist wins CIMT Audience Choice Award

The CIMT Annual Meeting Poster Jury awards each year six-early-career researchers.

RCI scientist Valentina Volpin, Ph.D, has received the 2021 CMIT Audience Choice award for her e-talk: “The serine/threonine kinase CAMK1D confers immune resistance of PD-L1  refractory tumor cells against tumor-reactive cytotoxic T cells.”

“Winning this prize is an important achievement for my career, given the hard work and commitment that I have put into this project.”, says Volpin. It is an inspiring achievement to continue to do research with enthusiasm, knowing that I’m moving into the right direction to cure cancer with immunotherapies.”